45th Multicenter Airway Research Collaboration
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-54
SponsorMassachusetts General Hospital
About this trial
The study is a randomized controlled trial on the effect of emergency department initiation of Airsupra on acute asthma "recurrence" at 3 months and other related outcomes (acute asthma relapse, asthma control).
Eligibility criteria
Qualifiers
acute asthma
age 18.0 to 54.9 years
English and/or Spanish speaking
decision by ED attending to discharge patient to home on short course of systemic corticosteroids
Disqualifiers
involvement in the planning and/or conduct of the study
previous enrolment in the present study
prior diagnosis of COPD, chronic bronchitis, or emphysema
use of systemic corticosteroids in the past 2 weeks
Trial design
Treatments tested in this trial
- Airsupra
Treatment groups
1,860 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov